1 FINAL EXAM, 2011 Due: Friday, Dec 9, 5pm (NO LATE FINALS WILL BE ACCEPTED). Turn in finals to the Agard lab, room S414, in the box on Elena’s desk. Please type out your answers (you can draw in any diagrams but please use pen). Have your name, organism, and page number on each page (example: John Smith, Phage, Page 1 of 2). Start your answers for each organism on a new page, and staple each organism section separately. Please be explicit and detailed in your answers in order to receive full credit. Use correct nomenclature for gene and gene products. You must work alone without help from other people, but you can use any inanimate reference material. If you need a clarification on any of the questions contact: Angela: Worms, Flies Elena: Prokaryotes, S.cerevisiae Kate: Pombe, Mice The TAs are not allowed to discuss course content during the final exam. 2 GENETICS OF PROKARYOTES A. As mentioned in class, RecA and LexA are major components of the SOS response that allow E. coli cells to respond to DNA damage. A number of interesting alleles of the genes encoding these factors have been identified and were instrumental in elucidating their function. Describe how you would screen/select for the following alleles: 1. recA- (loss of function) 2. recAtif (tif = temperature-induced filamentation, an allele of recA that is activated at 42C but not at 37C) 3. lexA- (loss of function) 4. lexAind (lexA that is uninducible by treatments with DNA damaging agents. You can assume that both wild-type E. coli and any molecular genetic tool you would need is available to you (except access to the recA and lexA mutant alleles in question, of course). For each allele, describe a secondary test you would perform that would increase your confidence that you have the desired allele. Indicate whether your approach is a screen or selection, and whether you think each resulting allele is dominant or recessive. B. Fill out the following chart indicating whether the SOS response is ON (+) or OFF (-) in the various mutants at 42C, and under both non-inducing conditions (-UV) or upon activation (+UV): E. coli genotype WT treatment -UV +UV recA- recAtif lexA- lexAind recAlexA- recAtif lexAind 3 FUNGAL GENETICS Saccharomyces cerevisiae You are doing a screen for mutants affecting kinetochore function. You hypothesize that these mutants will be sensitive to the microtubule depolymerizing drug Nocodazole. Therefore, you look for Nocodazole sensitivity. You isolate 100 mutants (you are very hard working, and like round numbers). For all parts of all questions you won’t have cloned or sequenced any of these genes. You will just do genetics, without identifying the genes that are mutated for each of the complementation groups. You get 4 complementation groups, Group A: 47 Group B: 36 Group C: 16 Group D: 1 1) When you cross a mutant from one of the complementation groups to wildtype, you see something funny in your tetrads. You get the following: Nocodazole sensitive = N Sen Nocodazole resistant = N Res (This is the wildtype condition for this concentration) DEAD means the spore never grew into a colony Note that you are initially growing the tetrads up on normal plates (no drug) and subsequently replica plating them to the plate with Nocodazole. The dead spores didn’t grow into colonies on the first, normal plate. Tetrad 1 N Sen N Res N Sen N Res Tetrad 2 DEAD N Res N Res DEAD Tetrad 3 N Res N Sen N Sen N Res Tetrad 4 N Res DEAD DEAD N Res Tetrad 5 DEAD N Res N Res DEAD Tetrad 6 N Res N Sen N Sen N Res You cross this to a new wildtype, and it does the same thing, so you suspect that there could be a second mutation in your original mutant strain. A) What is the nature of the second mutation? B) Give the likely genotypes for the first two tetrads. For ease of discussion let us call the mutation responsible for the nocodazole sensitivity kin1-1 and we will call the second mutation mut1-1, with the two wild types being KIN1 and MUT1 respectively. C) Does the segregation suggest anything else about the location of the genes being examined 4 D) Which complementation group is this mutant likely to be in and why? 2) You had a dream in which two sumo wrestlers stopped battling to unite their strengths to fight a common enemy. You interpret this as a prophesy that two of the proteins affected in your mutants are functioning together as a dimer. Pick mutants from three of the complementation groups above (not including the one that gives the weird genetics in part 1) and explain EXACTLY how you might conduct an experiment to look at this. This will be a genetic experiment, not a biochemical one (since you don’t know what genes are affected). Moreover, this experiment will not prove that these two gene products act in one complex, but will provide evidence consistent with them functioning in a mutually dependent way. Include in your analysis exactly how all strains would be generated. That is, if you mention a strain of a given genotype, state how you would isolate that strain, in addition to explaining the experiment you would do. 3) Gene conversion was discovered in yeast. Yet, there was years of work preceding this studying genetics in peas, fruitflies and mice. Why wasn’t gene conversion found in these organisms? (Hint, it isn’t just because yeast geneticists are better) 5 Schizosaccharomyces pombe This question concerns the mechanisms by which cells maintain their gene expression states. Grewal and Klar (Cell, 1995) made an intriguing observation when they deleted a region of a S. pombe mat2/3 locus replaced with the ura4 gene (see diagram above). Deletion of the K region in this manner resulted in cells that had two phenotypes: FOA+/Ura- or FOA-/Ura+. (In contrast, an insertion of a ura4+ gene into the mat2/3 region results in silencing of the ura4+ gene). These cells occasionally switched from one phenotype to the other. Deletion of clr1+, clr2+, clr3+, clr4+, or swi6+ silencing genes in these strains resulted in a non-silenced phenotype (FOA-/Ura+). A cross was performed (shown above) between a FOA+/Ura- strain and a FOA-/Ura+ strain. (Note that both parental strains harbored a mutation in the endogenous ura4+ gene – this is not shown in the genotypes shown above). Meiotic progeny were dissected and allowed to germinate on rich media (YEA) and then replica-plated to –His, -Ura, or FOA media. In addition, colonies were replica-plated to nitrogen starvation medium and stained with iodine to detect sporulation, indicated by PMA+ above. Please answer each question below using 1 or 2 sentences. 6 a. Based on these data, what would you conclude about the inheritance of the silenced and expressed states of the ura4+ gene that was used to replace the K region? b. Following the segregation of the ura4+ gene expression state and the –His phenotype, describe the tetrad type (PD, NPD, T) of each of the ten tetrads shown above. c. What is the significance of your answer to part (b) concerning the location of the his gene? d. The authors of this work argued that the switch between the ura4+ “on” and “off” states represented an “epigenetic switch,” namely one in which a heritable change in cell phenotype occurred that did not involve a change in the DNA sequence. Use a diagram to suggest a mechanism by which DNA sequence changes could in theory mediate a reversible but heritable change in the expression of a gene (note: there are several possible mechanisms one could imagine – you need only describe one, but you will receive extra credit for more than one)? e. Experimentally, how would you use modern techniques to test your bioregulatory hypothesis (or hypotheses) for a genetic mechanism by which the K::ura4+ gene switches between its two states? f. ura4+ genes are normally silenced when inserted into the silenced region of the pombe mating type locus in a manner that does not delete sequences around the insertion site. Experimentally how would you obtain such strains if one cannot select for Ura+ transformants using your knowledge of silencing in S. pombe? g. Extra Credit: What does the iodine staining phenotype tell you about the relationship between mating type switching and silencing? 7 GENETICS OFTHE NEMATODE C. elegans You are studying programmed cell death, a conserved physiological process. C. elegans mutants with excess or reduced programmed cell death are known. Loss-of-function mutations in either ded-3 or ded-4 result in the survival of cells that normally die indicating that these genes are required for the killing process. By contrast, a gain of function mutation in ded-9 prevents most, if not all, programmed cell deaths while loss of function mutations in ded-9 cause embryonic lethality. Thus, ded-9 is a negative regulator of programmed cell death. Genetic and biochemical analyses established the following epistatic relationship: ded-9 --| ded-4 ded-3 programmed cell death In C. elegans, a number of cell divisions/fate choices occur post-embryonically. One example is the life/death decision of a pair of hermaphrodite specific neurons (HSN), which innervate the vulva and are required for egg-laying. HSN neurons are born but undergo programmed cell death in males. Hermaphrodites in which HSN neurons are inappropriately killed are egg-laying defective (egl). A mutagenesis screen looking for egl phenotypes identified egl-5(n1084) mutant animals in a standard F1/F2 screen. 100% of egl-5(n1084) progeny exhibit an egl phenotype. You initiate backcrossing egl5(n1084) hermaphrodites with wild type males and obtain the following results: P0: F1: egl-5(n1084)/egl-5(n1084) hermaphrodite X wild type males You recover both males and hermaphrodites; ~75% of hermaphrodite progeny exhibit the egl phenotype 1. What do you conclude about the nature of (n1084) mutation? Using the egl phenotype you map egl-5(n1084) to a small region on chromosome V, however, you still haven’t nailed down its molecular identity just yet. There is a previously reported C. elegans strain, nDf42, which carries a deletion (a deficiency) corresponding to this very region of chromosome V. The region corresponding to nDf42 deletes several tens of predicted genes. You obtain the following results in hermaphrodites: Table I. Genotype Wild type (+/+) egl-5(n1084)/egl-5(n1084) egl-5(n1084)/ + nDf42/+ egl-5(n1084)/ nDf42 % Egg laying defective 1 99 71 1 68 %HSN surviving 100 0 27 92 42 8 2) Comparing egl-5(n1084)/+ and egl-5(n1084)/nDf42, do these results support or refute your conclusion from question 1 regarding the nature of the egl-5(n1084) allele? What do the results of nDf42/+ allow you to rule out? To answer these questions, think in terms of recessive, dominant, haploinsufficient, etc. 3) To understand the role of egl-5 in programmed cell death, you are told to examine loss of function mutations in egl-5. Why is that? To isolate dominant suppressors of egl-5(n1084), you mutagenize egl-5(n1084)/egl5(n1084) hermaphrodites and screen through the resulting F1 progeny for rare animals that display normal egg-laying and retain their HSN neurons. You identify a suppressor (n3082) and determine that this suppressor is very tightly linked to the egl-5 locus. Now that you have a suppressor strain, egl-5(n1084 n3082), you examine HSN survival as well as survival of other cells that normally undergo apoptosis in hermaphrodites (same table as above, now with extra data added): Genotype % Egg laying defective Wild type (+/+) 1 egl-5(n1084)/(n1084 100 egl-5(n1084)/ + 71 nDf42/+ 1 egl-5(n1084)/nDf42 68 egl-5(n1084 n3082)/(n1084 n3082) 0 egl-5(n1084 n3082)/ + 0 egl-5(n1084 n3082)/nDf42 1 %HSN surviving 100 0 27 92 42 97 98 100 extra cells ? no no ND no ND Yes no Yes ND=not determined 4) What does the observation that the n3082 suppressor is tightly linked to egl5(n1084) suggest about the mutation? 5) From the data in the table above, what type of allele is n3082 likely to be (e.g. loss of function, gain of function,…)? Given this, what do you conclude about the likely role of egl-5 in programmed cell death and in HSN? 6) Now that you know the molecular identity of egl-5, suggest an easy experiment to verify your conclusions regarding the role of this gene in programmed cell death and HSN survival. You identify the molecular identity of the egl-5 gene. It encodes a novel protein. To determine the relationship of egl-5 and other components of cell death machinery, you use P mec-7, a promoter that becomes activated only in a small number of cells, including the six touch cell neurons of C. elegans. These touch cells are readily identifiable. These 9 cells are normally present in adult hermaphrodites. Animals that lack these cells are viable but unresponsive to touch. Expression of wild type ded-3 or ded-4 under Pmec-7 promoter causes death of the touch cells (and ded-3, ded-4, and ded-9 are expressed throughout the animal). You obtain the following data for various indicated transgenic animals: Table 2. Transgene % touch cells surviving Pmec-7 (promoter alone) 100% Pmec-7 egl-5(wild type) 8% Pmec-7 egl-5; ded-9(gain of function) 100% Pmec-7 egl-5; ded-4 (loss of function) 97% Pmec-7 egl-5; ded-3 (loss of function) 98% 7) Based on these data draw a genetic pathway of how egl-5 may fit with the cell death pathway (ded-9 --| ded-4 ded-3 programmed cell death). It was previously shown that DED-9 normally binds DED-4. You now find that EGL-5 pulls down DED-9, however, any time that you use EGL-5 to pull down DED-9, you don’t see DED-4 coming down with DED-9. 8) Describe in a few sentences a model that is consistent with the genetic and the biochemical findings. Extra credit: You determine that the n1084 mutation causes a point mutation within a stretch of DNA downstream of the coding region of the egl-5 while n3082 causes a 5bp deletion at the beginning of exon 2. The n3082 deletion is predicted to result in a frameshift leading to generation of a truncated protein composed of the first half of the wild type protein and a 16 amino acid C-terminal extension in a different reading frame. Moreover, you discover that FRAU-1, a transcription factor, binds to the DNA region corresponding to the n1084 allele. FRAU-1 is expressed in the HSN neurons of hermaphrodites but not males. Come up with a model that is consistent with all of the data presented that could explain how HSN neurons undergo programmed cell death in males but survive in hermaphrodites. Include your conclusions/assumptions about the role of egl-5 in programmed cell death, its activity in the HSN neurons, and the nature of the n1084 and n3082 alleles. Please include a diagram to illustrate your model. 10 FLY GENETICS General Background: You are interested in a curious sexual dimorphorism: the adult males of many higher insects (this includes the diptera and Drosophila are dipteran – two winged) have one less abdominal segment than the female. The larvae of both sexes have the same number of segments but a specific segment is deleted during pupal development of males. The segments of the adult are produced from nests of diploid cells that appear during embryogenesis but remain quiescent (don’t divide) throughout embryonic and larval life and then grow and divide rapidly at the beginning of pupal development. The cells in these nests are called histoblasts. Each larval segment has four nests (a dorsal and a ventral one, on both the left and right sides) that produce the corresponding parts of the abdominal segment. Each nest has about 16 cells that have been arrested in G2, since embryogenesis (i.e. during all larval stages). It is known that the male and female larvae have the same number of nests. Since a specific segment fails to develop in males, some sexually regulated modification oblates histoblasts in the segment that is deleted, or perhaps curtails their development. You are interested in figuring out how this regulation works. In order to investigate the fate of the histoblasts, you need a way of positively marking histoblasts to track them throughout pupal development. If you can mark them you can follow the growth, development and possible elimination of the hisotoblasts from the segment (A7) that is deleted in males to the histoblasts of the adjacent segment. By tracking what happens in male and female pupae and in different mutants, you will be able to figure out all sorts of things. But first, you have to mark the cells and for this question that is the only thing you have to deal with. Some specifics: There is a gene called escargot (esg) that is a transcription factor expressed in the diploid cells (i.e. not in larval cells which are polytene). The only cells in the abdomen of the larvae that express esg are the histoblasts. You have an esg-GAL4 transgene that expresses GAL4 in the histoblasts starting shortly after the histoblasts arise during embryonic life. BUT esg expression (and the esg-GAL4 transgene) shuts off toward the beginning of pupation and there is no residue of the earlier expression after the first two of the pupal cell cycles; however, you want to track the cells through many cell cycles and to follow their fate throughout pupal development. I would like you to describe an approach that would allow you to mark the cells utilizing esg-Gal4. For one third of the points – come up with a method to mark the histoblasts throughout pupal development. For full points, 1) write a few sentences describing how your system accomplishes this, 2) write out the genotype of the flies carrying your marker system that you will observe (specify on which chromosome each element/gene you are using is located), and 3) write a sentence or two describing each of the transgenes you are using 11 (their properties relevant to this problem - not all the details and not a discourse on Pelements). For another third of the points - come up with one alternative way to mark the histoblasts throughout pupal development (note that your first and alternative approaches do not have to equally practical). For full points, 1) write a few sentences describing how your system accomplishes this, 2) write out the genotype of the flies carrying your marker system that you will observe (specify on which chromosome each element/gene you are using is located), and 3) write a sentence or two describing each of the transgenes you are using (their relevant properties - not their sequence and all the details). In addition, of the ways you came up with, identify the better of the approaches and indicate why it is better-suited to your goal. Finally, to see how practical your marking system is, describe how it would be used to address the following: A gene called doublesex (dsx) located at 86E (on the right arm of the 3rd chromosome) plays an important role in the regulatory cascade controlling sexual traits. The dsx transcript is alternatively spliced in males and females. You have a mutant that specifically inactivates the male isoform of dsx, dsxm. It behaves as a recessive mutation that only affects males. The homozygous males are viable but exhibit some female traits and they are sterile. Notably, the sterile males have an A7 abdominal segment (i.e. Dsxm is required for the male specific segment elimination). You have a stock of this mutation with a third chromosome balancer, TM6-Sb. Note that this stock has non-Sb flies that are homozygous for dsxm, but the balancer is maintained in the stock because the only fertile males are heterozygous. You want to follow the effect of dsxm on the fate of the histoblasts in A7. Some hopefully helpful notes: When you are working out a crossing scheme, it is easiest to work backwards, describing the genotype you want then defining the parents that will give the desired genotype and grandparents that will give you the desired parents. Sometimes many generations are required in elaborate strain constructions. Here, I want to limit the problem to the final generation that produces the experimentally relevant progeny. Note that the progeny that you will examine will be pupae not adult flies. Many of the markers (e.g. Cy) used to follow genotype will not be scorable in the pupae. Fortunately, GFP expression is visible, and, if you need them, there are a few markers that are scorable in pupae (e.g. Tubby – a dominant 3rd chromosome marker that affects body shape). For the final third of the points, 1) Write out the genotype of the fly (actually a pupa) in which you can observe the effect of dsxm on the histoblasts in A7, utilizing the BETTER of the two systems you came up with. 2) Write out the immediate parents of this fly and illustrate how you would cross them together to produce the fly in question. Draw out all the possible progeny and how you would select for the proper genotype of the fly in 12 which you can observe the effect of dsxm on the histoblasts in A7. Feel free to come up with various markers/Balancers, but please indicate their properties, especially if they are of your own invention. Be sure to indicate the fraction of progeny exhibiting the desired genotype and indicate if there are issues or tricks to identifying the desired progeny. If you see issues that arise with your scheme (for example, you might find the crosses cumbersome because the desired progeny class is rare, or the chromosomes are hard to follow) identify what makes it difficult and propose adjustments that might make it simple. 13 MOUSE GENETICS Recent work has identified the recessive locus, hyde, underlying extreme aggression in humans. The gene encodes a protein Hyde with no known functional domains. You are working on social behaviors in mice and find by browsing on the ensembl site that the gene is conserved across mammals. The mouse hyde locus looks like: not to scale Your in situ hybridization studies on the developing and adult brain show hyde to be expressed only in the adult amygdala, a region known to be involved in aggression but not essential for viability. Intrigued, you decide to knockout hyde in the mouse to assess its role in behavior. 1) Design a gene targeting strategy to generate a constitutive null allele such that it also labels Hyde expressing cells. Given that you have no idea what the two exons encode, you will have to make a judgment call as to what construct is most likely to yield a null allele. Please draw the construct and detail the targeting strategy and breeding needed to obtain hyde/- mice. After you have successfully obtained your hyde/- mice, you cross them to each other to generate null animals (-/-) so that you can do some behavioral testing on them. However, your crosses yield a smaller litter size and no null mice. 2a) Why this failure to obtain liveborn hyde null mice? 2b) How do you test your hypothesis? 2c) How do you reconcile these findings with the data from humans? Please provide at least 2 different reasons. You are still determined to test whether Hyde function in the mouse brain controls aggressive type interactions. 3a) Please design a genetic strategy to do so. Assume you have access to the desired promoters should your strategy call for one. Once again, draw the construct(s), detail the targeting strategy, breeding, and any functional validation needed to generate the mice you will use for your studies. 14 3b) Please detail the breeding required to generate your experimental and control mice for the behavioral studies.